All News

Today is April 10, 2021. All times in Eastern Daylight Time.

Greenwich LifeSciences Presents Immune Response Phase IIb Poster, Published Today at AACR 2021, Showing Peak Immunity after 6 Months of GP2 Treatment, Resulting in 100% Disease Free Survival from Recurring Breast Cancer

04/10/2021 - 04:13 PM

BUSINESS WIRE
Le test métallurgique de Lomiko au site de La Loutre produit un grade de concentré de 97,8% de carbone et de 93,5% de récupération de graphite

04/10/2021 - 03:54 PM

BUSINESS WIRE
EQUITY ALERT: Rosen Law Firm Files Securities Class Action Lawsuit on Behalf of Champignon Brands Inc. Investors – SHRMF

04/10/2021 - 12:47 PM

BUSINESS WIRE
AHF Welcomes Biden’s Proposed 15% HUD Budget Increase

04/10/2021 - 12:14 PM

BUSINESS WIRE
EIG ondertekent infrastructuurovereenkomst van $ 12,4 miljard met Aramco

04/10/2021 - 11:54 AM

BUSINESS WIRE
Voluntary Recall of Hostess® SnoBalls® Due to Undeclared Allergen

04/10/2021 - 10:34 AM

BUSINESS WIRE
GlycoMimetics to Present at AACR 2021 Meeting on Positive Therapeutic Effects of GMI-1757 in a Pancreatic Adenocarcinoma Model

04/10/2021 - 09:00 AM

BUSINESS WIRE
Positive Findings From Phase 1b Trial of GlycoMimetics’ GMI-1359 To Be Presented at AACR 2021 Meeting

04/10/2021 - 09:00 AM

BUSINESS WIRE
Ultimovacs Presents the INITIUM Study Design as a Trial-in-Progress Poster at AACR Annual Meeting 2021

04/10/2021 - 08:35 AM

BUSINESS WIRE
Data at AACR Demonstrate Growing Clinical Utility of Guardant Health Liquid Biopsies in the Treatment and Management of Advanced Cancers

04/10/2021 - 08:35 AM

BUSINESS WIRE
Investigational Combination of Aliqopa® (copanlisib) and rituximab Significantly Increases Progression-Free Survival in Patients with Relapsed Indolent non-Hodgkin's Lymphoma

04/10/2021 - 08:33 AM

BUSINESS WIRE
Arcus Biosciences Presents Updated Data for Etrumadenant in Third-Line Metastatic Colorectal Cancer and New Data on its HIF-2α Program at the AACR 2021 Annual Meeting

04/10/2021 - 08:33 AM

BUSINESS WIRE
Biodesix Releases New Data at AACR on Proteomic Profiling to Help Guide Physician Treatment Strategies for NSCLC Patients

04/10/2021 - 08:30 AM

BUSINESS WIRE
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE
Freenome Presents Data Revealing Signatures of Immune Checkpoint Inhibitor Treatment Response Found to Be Common Across Kidney, Melanoma, and Lung Cancers

04/10/2021 - 08:30 AM

BUSINESS WIRE
Zymeworks Showcases Preclinical Assets, Including New Therapeutic Platform, ProTECT™, and Zanidatamab Mechanisms of Action at AACR Annual Meeting

04/10/2021 - 08:30 AM

BUSINESS WIRE
Bicycle Therapeutics Announces Presentations at the AACR Annual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE
Synthekine Presents Data at AACR Annual Meeting 2021 Demonstrating Selective IL-2 Partial Agonist, STK-012, Promotes Anti-Tumor Response without Related Toxicities

04/10/2021 - 08:30 AM

BUSINESS WIRE
OncoMyx Presents at AACR First Data Showing Multi-Armed Myxoma Virotherapy Can Modulate Anti-Tumor Immune Response

04/10/2021 - 08:30 AM

BUSINESS WIRE
SQZ Biotech Presents Preclinical Data on its mRNA-based enhanced APCs and the Potential of the SQZ APC Platform in KRAS Driven Tumors

04/10/2021 - 08:30 AM

BUSINESS WIRE
Neoadjuvant Opdivo (nivolumab) Plus Chemotherapy Significantly Improves Pathologic Complete Response in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial

04/10/2021 - 08:30 AM

BUSINESS WIRE
Boundless Bio Presents Data on the Role of Extrachromosomal DNA (ecDNA) in Mediating Resistance to Targeted Therapies at the American Association for Cancer Research (AACR) Annual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE
Tachyon Presents Promising Preclinical Data on Its First-in-class Pan-KDM4 Epigenetic Regulator, TACH101

04/10/2021 - 08:30 AM

BUSINESS WIRE
ITM Presents Design for Ongoing Phase III COMPETE Trial with n.c.a. 177Lu-Edotreotide at AACR Annual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE
Clovis Oncology Highlights Rubraca® (rucaparib) Clinical Data at AACR Virtual Annual Meeting 2021

04/10/2021 - 08:30 AM

BUSINESS WIRE

1 2 3 4 5 6 7 8 9 10 11 ... 678

Next »

Search